首页 | 本学科首页   官方微博 | 高级检索  
     

国产长春瑞滨联合顺铂治疗晚期非小细胞肺癌的临床观察
引用本文:马锐,伞宝君. 国产长春瑞滨联合顺铂治疗晚期非小细胞肺癌的临床观察[J]. 临床肿瘤学杂志, 2003, 8(4): 296-297
作者姓名:马锐  伞宝君
作者单位:110042,沈阳,辽宁省肿瘤医院内二科
摘    要:目的:观察抗肿瘤新药国产长春瑞滨(NVB盖诺)加顺铂(DDP)联合化疗治疗晚期非小细胞肺癌(NSCLC)的疗效。方法:治疗NSCLC48例。男性34例,女性14例。病理类型以腺癌为主(28例)。结果:部分缓解(PR)21例,稳定(NC)24例,进展(PD)3例,总有效率47.92%。盖诺的剂量限制毒性为骨髓抑制,白细胞下降占81.25%。局部疼痛或静脉炎发生率29.17%。结论:以盖诺为主联合化疗治疗晚期NSCLC的有效率高,毒性可以耐受,是一个有前途的抗肿瘤新药。

关 键 词:长春瑞滨 顺铂 联合治疗 晚期非小细胞肺癌 临床观察 化疗 疗效
文章编号:1009-0460(2003)04-0296-02
修稿时间:2002-05-28

Homemade Vinorelbine based combination chemotherapy in non-small cell lung cancer
MA Rui,SAN Bao-jun. Homemade Vinorelbine based combination chemotherapy in non-small cell lung cancer[J]. Chinese Clinical Oncology, 2003, 8(4): 296-297
Authors:MA Rui  SAN Bao-jun
Affiliation:MA Rui,SAN Bao-jun.Department of Medical Oncology Liaoning Province Tumor Hospital,Shenyang 110042
Abstract:Objective:To evaluate the results of combination chemotherapy with vinorelbine(VNLB) plus cisplatin (DDP) in the treatment of non-small cell lung cancer(NSCLC).Methods:Forty-eight patients with advanced NSCLC were enrolled in this study.Adenocarcinoma was the most common type of malignancy.Results:The overall rate was 47.92%.The dose limiting toxicity was neutropenia which was seen 81.25% in treated cases.The local venous toxicity was observed in 29.17% of the patients.Conclusion:A high response rate was obtained in advanced NSCLC treated by NVB plus DDP.NVB is a promising antitumor agent with tolerable toxicity.
Keywords:Non-small-cell lung cancer  Chemotherapy  Vinorelbin  Cisplatin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号